Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.
Federica BielloFrancesca PlatiniFrancesca D'AvanzoCarlo CattriniAlessia MennittoSilvia GenestroniVeronica MartiniPaolo MarzulloGianluca AimarettiAlessandra GennariPublished in: Biomolecules (2021)
Obesity, metabolic syndrome, and insulin resistance are all involved in BC growth and could have a relevant impact on prognosis. All these factors act through a pro-inflammatory state, mediated by cytokines originated in fat tissue, and seem to be related to a higher risk of BC development and worse prognosis.